Mirae Asset Global Investments
ACET icon

Mirae Asset Global Investments’s Adicet Bio ACET Stock Holding History

Mirae Asset Global Investments’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-740
Closed -$65.3K – 1536
2024
Q1 		$65.3K Buy
+740
New +$30.6K ﹤0.01% 2414
2023
Q3 		– Sell
-800
Closed -$31.1K – 2570
2023
Q2 		$31.1K Sell
800
-6
-0.7% -$530 ﹤0.01% 2601
2023
Q1 		$74.2K Sell
806
-1
-0.1% -$125 ﹤0.01% 2486
2022
Q4 		$115K Buy
807
+5
+0.6% +$1.25K ﹤0.01% 2433
2022
Q3 		$182K Buy
+802
New +$204K ﹤0.01% 2372

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Mirae Asset Global Investments's ACET Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 740 shares — an estimated $65.3K sold.

Mirae Asset Global Investments first reported a position in ACET in Q3 2022 and held it in 5 quarters. The position peaked at $182K in Q3 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 740 Adicet Bio shares in Q2 2024, an estimated $65.3K.
  • Mirae Asset Global Investments first reported a position in Adicet Bio in Q3 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Adicet Bio position peaked at $182K in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.